The future of the COVID-19 pandemic: How good (or bad) can the SARS-CoV2 spike protein get?
MA Nugent - Cells, 2022 - mdpi.com
Severe acute respiratory syndrome virus 2 (SARS-CoV2) has infected an estimated 400
million people world-wide, causing approximately 6 million deaths from severe coronavirus …
million people world-wide, causing approximately 6 million deaths from severe coronavirus …
Single-molecule analysis of SARS-CoV-2 binding to c-type lectin receptors
JD Simpson, A Ray, C Marcon… - Nano …, 2023 - ACS Publications
Despite intense scrutiny throughout the pandemic, development of efficacious drugs against
SARS-CoV-2 spread remains hindered. Understanding the underlying mechanisms of viral …
SARS-CoV-2 spread remains hindered. Understanding the underlying mechanisms of viral …
Nanomaterial-Based Biosensors for SARS-CoV-2 and Future Epidemics
The outbreak of the coronavirus disease 2019 (COVID-19) pandemic has put enormous
pressure on global healthcare and economic systems. 1− 5 The cause of this pandemic …
pressure on global healthcare and economic systems. 1− 5 The cause of this pandemic …
Design of three residues peptides against SARS-CoV-2 infection
The continuous and rapid spread of the COVID-19 pandemic has emphasized the need to
seek new therapeutic and prophylactic treatments. Peptide inhibitors are a valid alternative …
seek new therapeutic and prophylactic treatments. Peptide inhibitors are a valid alternative …
Immunogenicity, effectiveness, safety and psychological impact of COVID-19 mRNA vaccines
A Alesci, M Gitto, M Kotańska, PL Cascio, A Miller… - Human Immunology, 2022 - Elsevier
In December 2019, a new single-stranded RNA coronavirus, SARS-CoV-2, appeared in
China and quickly spread around the world leading to a pandemic. Infection with SARS-CoV …
China and quickly spread around the world leading to a pandemic. Infection with SARS-CoV …
Structure-based drug design of RdRp inhibitors against SARS-CoV-2
K Shehzadi, A Saba, M Yu, J Liang - Topics in Current Chemistry, 2023 - Springer
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
worldwide pandemic since 2019, spreading rapidly and posing a significant threat to human …
worldwide pandemic since 2019, spreading rapidly and posing a significant threat to human …
An immunological review of SARS-CoV-2 infection and vaccine serology: innate and adaptive responses to mRNA, adenovirus, inactivated and protein subunit …
The coronavirus disease 2019 (COVID-19) pandemic is caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, which is defined by its positive …
respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, which is defined by its positive …
The impact of COVID-19 on cancer patients
D Wekking, TH Senevirathne, JL Pearce… - Cytokine & Growth …, 2023 - Elsevier
The COVID-19 pandemic poses a significant challenge for individuals with compromised
immune systems, such as patients with cancer, as they face a heightened susceptibility to …
immune systems, such as patients with cancer, as they face a heightened susceptibility to …
Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys
M Hashimoto, N Nagata, T Homma, H Maeda, K Dohi… - Vaccine, 2022 - Elsevier
The vaccine S-268019-b is a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) spike (S)-protein vaccine consisting of full-length recombinant SARS-CoV-2 S-protein (S …
2) spike (S)-protein vaccine consisting of full-length recombinant SARS-CoV-2 S-protein (S …
Neutralizing ability of a single domain VNAR antibody: in vitro neutralization of SARS-CoV-2 variants of concern
BJ Valdovino-Navarro, S Dueñas… - International Journal of …, 2022 - mdpi.com
Severe Acute Respiratory Syndrome Coronavirus 2 is the causal pathogen of coronavirus
disease 2019 (COVID-19). The emergence of new variants with different mutational patterns …
disease 2019 (COVID-19). The emergence of new variants with different mutational patterns …